Based on the Elbit Imaging Ltd stock forecast from 0 analysts, the average analyst target price for Elbit Imaging Ltd is not available over the next 12 months. Elbit Imaging Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Elbit Imaging Ltd is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, Elbit Imaging Ltd’s stock price was USD 0.85. Elbit Imaging Ltd’s stock price has changed by +0.00% over the past week, -15.00% over the past month and +3,441.67% over the last year.
No recent analyst target price found for Elbit Imaging Ltd
No recent average analyst rating found for Elbit Imaging Ltd
Company Overview Elbit Imaging Ltd
Elbit Imaging Ltd., together with its subsidiaries, develops, produces, and markets therapeutic medical systems for performing non-invasive treatments on the human body in Israel and internationally. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was formerly known as Elbit Medical Imaging Ltd. and changed its name to Elbit Imaging Ltd. in November 2007. Elbit Imaging Ltd. was incorporated in 1996 and is headquartered in Petach Tikva, Israel. Read Less
Elbit Imaging Ltd., together with its subsidiaries, develops, produces, and markets therapeutic medical systems for performing non-invasive treatments on the human body in Israel and internationally. The company offers treatment-oriented medical systems with ultrasound beam and m...Read More
Frequently Asked Questions About Elbit Imaging Ltd (EMITF) Stock
Stock Target Advisor's fundamental analysis for Elbit Imaging Ltd's stock is Neutral.
EMITF stock's dividend yield is 4.06%.
Our analysis grades EMITF stock's dividend yield at A. This means that EMITF stock's dividend yield is above 93% of the stocks in the Medical Devices sector in the OTC exchange.
Based on this EMITF may be a good dividend stock for its sector.
Unfortunately we do not have enough data on EMITF's stock to indicate what its average analyst target is.
EMITF stock's Price/Earning ratio is 0.97.
Our analysis grades EMITF stock's Price / Earning ratio at B. This means that EMITF stock's Price/Earning ratio is above 17% of the stocks in the Medical Devices sector in the OTC exchange.
Based on this EMITF may be undervalued for its sector.
The last closing price of EMITF's stock was USD 0.85.
The most recent market capitalization for EMITF is USD 9.39M.
Unfortunately we do not have enough analyst data on EMITF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Elbit Imaging Ltd's stock.
As per our most recent records Elbit Imaging Ltd has 3 Employees.
Elbit Imaging Ltd's registered address is 3 Shimson Street, Petah Tikva, Israel, 4900102.
You can get more information about it from Elbit Imaging Ltd's website at http://www.elbitimaging.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for EMITF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
